Use of Human Umbilical Cord and Its Byproducts in Tissue Regeneration

Francesca Velarde; Verónica Castañeda; Emilia Morales; Mayra Ortega; Edwin Ocaña; Jose Álvarez-Barreto; Michelle Grunauer; Luis Eguiguren; Andrés Caicedo

doi:10.3389/fbioe.2020.00117

Use of Human Umbilical Cord and Its Byproducts in Tissue Regeneration

Francesca Velarde, Verónica Castañeda, Emilia Morales, Mayra Ortega, Edwin Ocaña, Jose Álvarez-Barreto, Michelle Grunauer, Luis Eguiguren^*, Andrés Caicedo

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

16 Scopus citations

Abstract

The fresh or cryopreserved human umbilical cord (HUC) and its byproducts, such as cells and extracts, have different uses in tissue regeneration. Defining what HUC byproduct is more effective in a particular application is a challenge. Furthermore, the methods of isolation, culture and preservation, may affect cell viability and regenerative properties. In this article, we review the HUC and its byproducts’ applications in research and clinical practice. We present our results of successful use of HUC as a patch to treat gastroschisis and its potential to be applied in other conditions. Our in vitro results show an increase in proliferation and migration of human fibroblasts by using an acellular HUC extract. Our goal is to promote standardization of procedures and point out that applications of HUC and its byproducts, as well as the resulting advances in regenerative medicine, will depend on rigorous quality control and on more research in this area.

Original language	English
Article number	117
Journal	Frontiers in Bioengineering and Biotechnology
Volume	8
DOIs	https://doi.org/10.3389/fbioe.2020.00117
State	Published - 10 Mar 2020

Bibliographical note

Funding Information:
We are grateful to the health professionals of Hospital Carlos Andrade Mar?n and to Drs. A. Zurita and S. Nicola for the care provided to the patients. AC would like to thank Sistemas Medicos-USFQ (SIME-USFQ) for their support. Funding. This research was funded by the USFQ School of Medicine Grant (institutional code: HUBi 5502). The USFQ evaluated this project before its submission to Frontiers through grant proposals and bioethics review processes according to institutional criteria. Funding bodies did not play any role in the design, data collection, analysis, and interpretations of data or in writing the manuscript.

Publisher Copyright:
© Copyright © 2020 Velarde, Castañeda, Morales, Ortega, Ocaña, Álvarez-Barreto, Grunauer, Eguiguren and Caicedo.

Keywords

cryopreserved allograft
gastroschisis
mesenchymal stem cells
regenerative medicine
tissue regeneration
umbilical cord
umbilical cord extracts
umbilical cord stem cells

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3389/fbioe.2020.00117

Cite this

@article{10e36d0c3a57443eaefd47d138386d6e,

title = "Use of Human Umbilical Cord and Its Byproducts in Tissue Regeneration",

abstract = "The fresh or cryopreserved human umbilical cord (HUC) and its byproducts, such as cells and extracts, have different uses in tissue regeneration. Defining what HUC byproduct is more effective in a particular application is a challenge. Furthermore, the methods of isolation, culture and preservation, may affect cell viability and regenerative properties. In this article, we review the HUC and its byproducts{\textquoteright} applications in research and clinical practice. We present our results of successful use of HUC as a patch to treat gastroschisis and its potential to be applied in other conditions. Our in vitro results show an increase in proliferation and migration of human fibroblasts by using an acellular HUC extract. Our goal is to promote standardization of procedures and point out that applications of HUC and its byproducts, as well as the resulting advances in regenerative medicine, will depend on rigorous quality control and on more research in this area.",

keywords = "cryopreserved allograft, gastroschisis, mesenchymal stem cells, regenerative medicine, tissue regeneration, umbilical cord, umbilical cord extracts, umbilical cord stem cells",

author = "Francesca Velarde and Ver{\'o}nica Casta{\~n}eda and Emilia Morales and Mayra Ortega and Edwin Oca{\~n}a and Jose {\'A}lvarez-Barreto and Michelle Grunauer and Luis Eguiguren and Andr{\'e}s Caicedo",

note = "Funding Information: We are grateful to the health professionals of Hospital Carlos Andrade Mar?n and to Drs. A. Zurita and S. Nicola for the care provided to the patients. AC would like to thank Sistemas Medicos-USFQ (SIME-USFQ) for their support. Funding. This research was funded by the USFQ School of Medicine Grant (institutional code: HUBi 5502). The USFQ evaluated this project before its submission to Frontiers through grant proposals and bioethics review processes according to institutional criteria. Funding bodies did not play any role in the design, data collection, analysis, and interpretations of data or in writing the manuscript. Publisher Copyright: {\textcopyright} Copyright {\textcopyright} 2020 Velarde, Casta{\~n}eda, Morales, Ortega, Oca{\~n}a, {\'A}lvarez-Barreto, Grunauer, Eguiguren and Caicedo.",

year = "2020",

month = mar,

day = "10",

doi = "10.3389/fbioe.2020.00117",

language = "English",

volume = "8",

journal = "Frontiers in Bioengineering and Biotechnology",

issn = "2296-4185",

publisher = "Frontiers Media S.A.",

}

TY - JOUR

T1 - Use of Human Umbilical Cord and Its Byproducts in Tissue Regeneration

AU - Velarde, Francesca

AU - Castañeda, Verónica

AU - Morales, Emilia

AU - Ortega, Mayra

AU - Ocaña, Edwin

AU - Álvarez-Barreto, Jose

AU - Grunauer, Michelle

AU - Eguiguren, Luis

AU - Caicedo, Andrés

N1 - Funding Information: We are grateful to the health professionals of Hospital Carlos Andrade Mar?n and to Drs. A. Zurita and S. Nicola for the care provided to the patients. AC would like to thank Sistemas Medicos-USFQ (SIME-USFQ) for their support. Funding. This research was funded by the USFQ School of Medicine Grant (institutional code: HUBi 5502). The USFQ evaluated this project before its submission to Frontiers through grant proposals and bioethics review processes according to institutional criteria. Funding bodies did not play any role in the design, data collection, analysis, and interpretations of data or in writing the manuscript. Publisher Copyright: © Copyright © 2020 Velarde, Castañeda, Morales, Ortega, Ocaña, Álvarez-Barreto, Grunauer, Eguiguren and Caicedo.

PY - 2020/3/10

Y1 - 2020/3/10

N2 - The fresh or cryopreserved human umbilical cord (HUC) and its byproducts, such as cells and extracts, have different uses in tissue regeneration. Defining what HUC byproduct is more effective in a particular application is a challenge. Furthermore, the methods of isolation, culture and preservation, may affect cell viability and regenerative properties. In this article, we review the HUC and its byproducts’ applications in research and clinical practice. We present our results of successful use of HUC as a patch to treat gastroschisis and its potential to be applied in other conditions. Our in vitro results show an increase in proliferation and migration of human fibroblasts by using an acellular HUC extract. Our goal is to promote standardization of procedures and point out that applications of HUC and its byproducts, as well as the resulting advances in regenerative medicine, will depend on rigorous quality control and on more research in this area.

AB - The fresh or cryopreserved human umbilical cord (HUC) and its byproducts, such as cells and extracts, have different uses in tissue regeneration. Defining what HUC byproduct is more effective in a particular application is a challenge. Furthermore, the methods of isolation, culture and preservation, may affect cell viability and regenerative properties. In this article, we review the HUC and its byproducts’ applications in research and clinical practice. We present our results of successful use of HUC as a patch to treat gastroschisis and its potential to be applied in other conditions. Our in vitro results show an increase in proliferation and migration of human fibroblasts by using an acellular HUC extract. Our goal is to promote standardization of procedures and point out that applications of HUC and its byproducts, as well as the resulting advances in regenerative medicine, will depend on rigorous quality control and on more research in this area.

KW - cryopreserved allograft

KW - gastroschisis

KW - mesenchymal stem cells

KW - regenerative medicine

KW - tissue regeneration

KW - umbilical cord

KW - umbilical cord extracts

KW - umbilical cord stem cells

UR - http://www.scopus.com/inward/record.url?scp=85082691209&partnerID=8YFLogxK

U2 - 10.3389/fbioe.2020.00117

DO - 10.3389/fbioe.2020.00117

M3 - Article

AN - SCOPUS:85082691209

SN - 2296-4185

VL - 8

JO - Frontiers in Bioengineering and Biotechnology

JF - Frontiers in Bioengineering and Biotechnology

M1 - 117

ER -

Use of Human Umbilical Cord and Its Byproducts in Tissue Regeneration

Abstract

Bibliographical note

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this